Evidence map›Paper›PMID 41760320›Full record

ArticleIn vivo (Athens, Greece)

History of Chronic Obstructive Pulmonary Disease May Contribute to Earlier Diagnosis of Lung Cancer.

Miloslav Marel, Petr Domecky, Casas Mendez Luis Fernando, Alzbeta Bejckova, Libor Fila, Michal Hrnciarik, Tomas Vencalek, Jaromir Roubec, Jaroslav Duba, Martin Svaton

Abstract readMulticenter Study
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miloslav MarelDepartment of Pneumology, 2nd Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czech Republic.
Petr DomeckyDeparment of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
Casas Mendez Luis FernandoDepartment of Pneumology, 2nd Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czech Republic.
Alzbeta BejckovaDepartment of Pneumology, 2nd Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czech Republic.
Libor FilaDepartment of Pneumology, 2nd Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czech Republic.
Michal HrnciarikDepartment of Pneumology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine, Hradec Kralove, Czech Republic.
Tomas VencalekDepartment of Pneumology, The Liberec Region Hospital, Liberec, Czech Republic.
Jaromir RoubecPulmonary Department, AGEL Hospital, Ostrava, Czech Republic.
Jaroslav DubaOAKS Consulting s.r.o., Prague, Czech Republic.
Martin SvatonDepartment of Pneumology and Phthiseology, University Hospital in Pilsen, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic svatonm@fnplzen.cz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimLung cancer (LC) and chronic obstructive pulmonary disease (COPD) are significant diseases due to both their serious health consequences and their prevalence in the population. However, there is a lack of contemporary data on the relationship between these diseases in the context of modern LC treatments, particularly immunotherapy. The aim of this study was, therefore, to compare the characteristics and prognosis of patients with LC with or without COPD. PATIENTS AND

methodsThis retrospective multicentre study included all patients from the Czech LUCAS registry who had recorded baseline tumour characteristics and information on the presence or absence of COPD prior to LC diagnosis. Overall survival (OS) was assessed using Kaplan-Meier estimates, with differences between groups evaluated by the log-rank test and multivariate Cox regression model, adjusting for covariates and stratifying by disease stage when proportional hazards assumptions were violated.

resultsA total of 815 patients were included, of whom 264 (32%) had COPD as a comorbidity. These patients were significantly more often diagnosed at potentially operable stages (I-IIIA) compared to patients without COPD (31%

conclusionAlthough patients with LC and COPD are diagnosed at a lower clinical stage of LC (likely due to regular monitoring by pneumologists), this does not translate into improved prognosis, which is comparable to that of patients without COPD.

Indexed as

Early Detection of CancerLung NeoplasmsPulmonary Disease, Chronic ObstructiveAgedFemaleHumansKaplan-Meier EstimateMaleMiddle AgedNeoplasm StagingPrognosisRetrospective StudiesChronic obstructive pulmonary diseaselung cancerprognosis

Identifiers

PMID41760320
PMCPMC12949918

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.